礼来接近收购迷幻药开发商AtaiBeckley
2026-07-15 22:52:52
据彭博社报道，知情人士透露，礼来公司(Eli Lilly)正在谈判收购迷幻药开发商AtaiBeckley Inc.，凸显大型药企对曾经边缘的迷幻药领域兴趣日益增长。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
吉姆·克莱默：科技股涨势缺乏基本面支撑Next article：
世界杯 | 阿根廷球员举争议横幅恐遭罚款
